Correlation Between GW Pharmaceuticals and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GW Pharmaceuticals and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GW Pharmaceuticals and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GW Pharmaceuticals Plc and Bristol Myers Squibb, you can compare the effects of market volatilities on GW Pharmaceuticals and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GW Pharmaceuticals with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of GW Pharmaceuticals and Bristol Myers.

Diversification Opportunities for GW Pharmaceuticals and Bristol Myers

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GWPH and Bristol is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GW Pharmaceuticals Plc and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and GW Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GW Pharmaceuticals Plc are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of GW Pharmaceuticals i.e., GW Pharmaceuticals and Bristol Myers go up and down completely randomly.

Pair Corralation between GW Pharmaceuticals and Bristol Myers

If you would invest  4,904  in Bristol Myers Squibb on January 25, 2024 and sell it today you would lose (5.00) from holding Bristol Myers Squibb or give up 0.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

GW Pharmaceuticals Plc  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
GW Pharmaceuticals Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GW Pharmaceuticals Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, GW Pharmaceuticals is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.
Bristol Myers Squibb 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

GW Pharmaceuticals and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GW Pharmaceuticals and Bristol Myers

The main advantage of trading using opposite GW Pharmaceuticals and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GW Pharmaceuticals position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind GW Pharmaceuticals Plc and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.